1. Home
  2. ACON vs ISPC Comparison

ACON vs ISPC Comparison

Compare ACON & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aclarion Inc.

ACON

Aclarion Inc.

HOLD

Current Price

$3.37

Market Cap

3.5M

Sector

Technology

ML Signal

HOLD

Logo iSpecimen Inc.

ISPC

iSpecimen Inc.

HOLD

Current Price

$4.64

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACON
ISPC
Founded
2008
2009
Country
United States
United States
Employees
6
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Precision Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5M
3.8M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
ACON
ISPC
Price
$3.37
$4.64
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
133.1K
29.8M
Earning Date
05-14-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
87.03
EPS
N/A
N/A
Revenue
N/A
$1,928,998.00
Revenue This Year
$87.22
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.34
$0.10
52 Week High
$12.03
$2.16

Technical Indicators

Market Signals
Indicator
ACON
ISPC
Relative Strength Index (RSI) 50.19 97.93
Support Level $3.00 $0.40
Resistance Level $3.56 N/A
Average True Range (ATR) 0.29 0.09
MACD -0.01 0.29
Stochastic Oscillator 39.18 87.25

Price Performance

Historical Comparison
ACON
ISPC

About ACON Aclarion Inc.

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

About ISPC iSpecimen Inc.

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.

Share on Social Networks: